Protagonist Therapeutics raised $40,000,000 on , from Adage Capital Management, Canaan ....

Get alertedif Protagonist Therapeutics gets funded!
Investors:, , , , , , , ,
United States
Menlo Park
Key people:Michael Panaccio, Ph.D. (Director)
Dinesh Patel (President & CEO)
Dinesh Patel, PhD (Director, Executive Officer)
Nicholas Peace (Director)
Harold Selick, Ph.d. (Director)
Armen Shanafelt (Director)
Armen Shanafelt, Ph.D. (Director)
Mark Smythe (Vice President of Technology & Alliances)
Asish Xavier (Director)
David Y. Liu (Chief Scientific Officer)
Data sources: - AGA Research Foundation raises $10.5 million to support GI research Story: - Protagonist Therapeutics closes $40 million Series C financing #onmedic #ehealth #pharma - Protagonist Therapeutics raises $40 million Series C round. - News: Protagonist raises $40m to test oral peptides in IBD - Protagonist Therapeutics raised $40m in Series C vent... - Protagonist Therapeutics closes $40 million Series C financing #NdaBag - VatorNews - Daily funding roundup - July 17, 2015: Protagonist Therapeutics bagged $40M; Upstart raised $35M; Court.. - Protagonist Therapeutics Raises $40 MillionTo Advance IBD Oral Therapy Development #crohns - #Protagonist Therapeutics, #biotech #startup out of @UQ_news, has raised $40M to advance IBD oral peptide drugs
Protagonist Therapeutics has secured a 40M funding. Protagonist Therapeutics specializes in Biotechnology. The funding took place in July 16th, 2015.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!